Elevation Oncology Inc (ELEV)
0.58
-0.04
(-6.22%)
USD |
NASDAQ |
Nov 14, 12:01
Elevation Oncology Total Liabilities (Quarterly): 36.95M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 36.95M |
| June 30, 2024 | 33.68M |
| March 31, 2024 | 33.14M |
| December 31, 2023 | 34.28M |
| September 30, 2023 | 37.56M |
| June 30, 2023 | 38.19M |
| March 31, 2023 | 43.13M |
| December 31, 2022 | 45.13M |
| Date | Value |
|---|---|
| September 30, 2022 | 44.37M |
| June 30, 2022 | 19.10M |
| March 31, 2022 | 10.44M |
| December 31, 2021 | 8.797M |
| September 30, 2021 | 8.89M |
| June 30, 2021 | 3.725M |
| March 31, 2021 | 99.87M |
| December 31, 2020 | 103.99M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.725M
Minimum
Jun 2021
103.99M
Maximum
Dec 2020
37.58M
Average
35.61M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Protalix BioTherapeutics Inc | 62.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.30M |
| Shareholders Equity (Quarterly) | 69.36M |